Observational Study
Copyright ©The Author(s) 2016.
World J Hepatol. May 18, 2016; 8(14): 616-624
Published online May 18, 2016. doi: 10.4254/wjh.v8.i14.616
Table 1 Results of basic information and acoustic radiation force impulse/aspartate aminotransferase to platelet ratio index/Forns index of all examinees
GroupAge (yr)Gender (male/female)BMIARFIAPRIForns index
F0 (n = 40)39.8 ± 11.4530/1022.91 ± 2.311.09 (1.01, 1.21)0.19 (0.14, 0.28)5.58 ± 1.33
F1 (n = 41)33.07 ± 7.97133/822.37 ± 2.241.19 (1.15, 1.28)10.34 (0.28, 0.44)15.60 ± 1.19
F2 (n = 52)38.27 ± 7.66243/922.26 ± 2.411.31 (1.21, 1.43)1,20.42 (0.32, 0.64)16.73 ± 1.091,2
F3 (n = 59)39.83 ± 8.73247/1222.44 ± 2.571.52 (1.35, 1.64)1,2,30.45 (0.32, 0.86)1,27.58 ± 1.551,2,3
F4 (n = 54)43.85 ± 10.811,2,3,444/1022.35 ± 2.471.92 (1.74, 2.14)1,2,3,40.80 (0.51, 1.68)1,2,3,49.43 ± 2.301,2,3,4
χ2/F7.9070.9470.477176.043107.99249.501
P value< 0.0010.9180.753< 0.001< 0.001< 0.001
Table 2 Correlations of non-invasive tests with histological fibrosis stage by rank correlation analysis
Histological stagingNoninvasive testCorrelation (Spearman coefficient)95%CIP value
METAVIR classificationARFI0.8450.805-0.877< 0.001
APRI0.6410.561-0.709< 0.001
Forns index0.6440.564-0.711< 0.001
Table 3 Cut-off values of acoustic radiation force impulse and aspartate aminotransferase to platelet ratio index for the diagnosis of liver fibrosis (95%CI)
F1 F2 F3F4
ARFI
Cut-off (m/s)1.261.291.431.62
Sensitivity76.2% (69.80-81.90)83.6% (77.10-88.90)82.3% (74.00-88.80)90.7% (79.70-96.90)
Specificity95.0% (83.10-99.40)90.1% (89.50-97.60)89.5% (83.00-94.10)92.2% (87.40-95.60)
PPV99.1% (96.20-99.90)94.5% (91.90-99.10)86.9% (79.10-92.70)76.0% (64.40-86.30)
NPV35.9% (22.50-47.40)73.0% (63.10-81.40)85.6% (78.60-91.00)97.2% (93.70-99.10)
AUROC0.90 (0.86-0.94)a0.91 (0.87-0.95)a0.94 (0.90-0.96)a0.96 (0.93-0.98)a
APRI
Cut-off (m/s)0.300.410.490.44
Sensitivity84.0% (78.20-88.70)68.5% (60.80-75.50)63.7% (54.10-72.60)83.3% (70.70-92.10)
Specificity85.0% (70.20-94.30)82.7% (72.70-90.20)79.7% (71.90-86.20)67.2% (70.10-73.80)
PPV97.6% (94.20-99.30)89.0% (82.20-93.80)72.8% (62.90-81.20)41.7% (32.30-51.60)
NPV42.7% (30.00-56.10)56.3% (46.80-65.40)72.1% (64.00-79.20)93.5% (87.90-97.00)
AUROC0.92 (0.88-0.95)a0.84 (0.79-0.89)a0.79 (0.73-0.84)a0.82 (0.76-0.86)a
Table 4 Binary logistic regression of two variables in hepatic fibrosis ≥ F2
CombinationVariableRCSD of RCWaldP valueOR95%CI of OR
ARFI + APRIARFI9.111.4837.68< 0.0019085.54494.92-166789.07
APRI5.031.3015.07< 0.001153.0112.07-1939.04
Constant-13.271.9546.09< 0.001--
ARFI + Forns indexARFI8.671.4436.16< 0.0015824.00345.12-98280.97
Forns index0.700.1716.27< 0.0012.011.43-2.82
Constant-15.082.0852.68< 0.001--
Table 5 Comparing area under the receiver operating characteristic curve of acoustic radiation force impulse/acoustic radiation force impulse + aspartate aminotransferase to platelet ratio index/acoustic radiation force impulse + Forns index/acoustic radiation force impulse + aspartate aminotransferase to platelet ratio index + Forns index in patients with fibrosis stage ≥ F2
ComparisonAUROCDifference95%CI
ZP value
Lower limitUpper limit
ARFI0.9130.0270.0080.0462.7700.006
ARFI + APRI0.940
ARFI0.9130.0200.0010.0402.0910.037
ARFI + Forns index0.933
ARFI0.9130.0310.0100.0532.8930.004
ARFI + APRI + Forns index0.944
ARFI + APRI0.9400.007-0.0110.0250.7280.466
ARFI + Forns index0.933
ARFI + APRI0.9400.005-0.0050.0140.9580.338
ARFI + APRI + Forns index0.944
ARFI + Forns index0.9330.011-0.0010.0231.7890.074
ARFI + APRI + Forns index0.944